Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 26, Status: Authorised

Academia

Human medicines European public assessment report (EPAR): Kadcyla, trastuzumab emtansine, Date of authorisation: 15/11/2013, Revision: 17, Status: Authorised

Committee for Advanced Therapies (CAT): 18-20 February 2026, European Medicines Agency, Amsterdam, the Netherlands, from 18 February 2026 to 20 February 2026

Bioabsorbable orthopaedic screws - Notified body 0344 - 14/05/2024 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026

Minutes – Ad hoc Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 5 March 2026

Human medicines European public assessment report (EPAR): Vafseo, vadadustat, Date of authorisation: 24/04/2023, Revision: 5, Status: Authorised